Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma.
Where this comes from
- Record sourced from PubMed, PMID 32238805.
- Also identified by DOI 10.1038/s41467-020-15531-2 and PMC identifier 7113240.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.